My frustrations with the expectations being missed haven't

New Post Public Reply Private Reply Replies (0) Message Board
CDiddy 10Blade #13881
528
My frustrations with the expectations being missed haven't changed. It does feel good to see the SP move up, but it remains to be seen if it will continue. There does seem to be more potential good news coming, and the additional exposure certainly helps.

With that said, I'm not in the group that thinks we have arrived. I think we've made an important step, but still have many more steps to go.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Adecoagro Hits Record EBITDA Amid Rain Challenges

Updated Category News Views 112

Adecoagro Breaks Records Despite Hurdles Picture this: Adecoagro's financials rolling in like a freight train, with nine-month adjusted EBITDA hitting an unprecedented $471.8 million. But hold on, it wasn't all smooth sailing. That kind of growth often comes with its own set of challenges, and this round wasn't any different for the South American agricultural...

Continue Reading
Brigham Nurses Secure Contract, Avoid Historic Strike

Updated Category News Views 77

Victory for Brigham Nurses: Tentative Contract Reached Against a backdrop of looming unrest, over 4,000 registered nurses at Brigham and Women's Hospital have inked a tentative contract with Mass General Brigham. This isn't just a deal—it's relief to a near-crisis that would have kicked off with an open-ended strike. Standoff Averted at the Eleventh Hour How about...

Continue Reading
Madrigal Faces Troubling Whistleblower Claims

Updated Category News Views 69

Whistleblower Complaint Rocks Madrigal Let me tell you, today's chatter isn't for the faint-hearted investor. Madrigal Pharmaceuticals (NASDAQ: MDGL) is under scrutiny, and it's making waves. The gears started turning when their former Senior VP and Head of Clinical Development unloaded a bombshell: he reported dirt on Madrigal's safety and efficacy data for Rezdiffra,...

Continue Reading
Huntsman Declares Q4 Dividend: $0.0875 Per Share

Updated Category News Views 11

Huntsman Corporation Delivers Dividend Update So, here's the lowdown from Huntsman Corporation coming at us on a rather sleepy November morning in 2026. They've announced their fourth quarter dividend—a neat $0.0875 per share. Now, this isn’t exactly hitting us like a seismic shockwave, but every little drip counts when you're invested in NYSE:HUN, which is exactly...

Continue Reading
GovCIO Revamps VA.gov for a Seamless Veteran Experience

Updated Category News Views 119

Diving Into the VA.gov Overhaul In the world of digital transformations, nobody bats an eye anymore unless there's real value on the table. Well, GovCIO's latest shake-up of VA.gov is exactly the sort of move that demands a second look. This isn't just typical IT handiwork—what we're seeing is a fundamental shift in how the Department of Veterans Affairs (VA) engages...

Continue Reading
ThreatBook Maintains High Ranking in Gartner's NDR Report

Updated Category News Views 212

ThreatBook: Standing Firm in NDR These days, if you're not keeping your cyber front secure, well, you're asking for trouble. In this digital age, when the bells and whistles of Network Detection and Response (NDR) chime, ThreatBook is one name that keeps echoing. For the fourth consecutive year, this cybersecurity stalwart nails it in Gartner's 'Voice of the Customer'...

Continue Reading
Peanuts and Diabetes: A Surprising Health Link

Updated Category News Views 95

A Nutty Approach to Diabetes Prevention Who would've thought peanuts could pack such a punch against diabetes? Amid the usual suspects of healthy foods, it's these humble legumes that are making headlines. The Peanut Institute, backed by fresh research, is shining a spotlight on their potential role in preventing type 2 diabetes, a disease that's affecting roughly 40...

Continue Reading
AI Shakes Up Boat Discovery: Traffic Soars for Leaders

Updated Category News Views 62

AI's Surge in the Boating World Well, look who’s riding the AI wave—it's our old friends at Boat Trader and YachtWorld, leaving the competition coughing in their slipstream. Similarweb data throws some cold, hard fish onto the deck, showing these two raking in over 17 times the AI-referred traffic compared to their closest peers. If you’re sniffing around for where...

Continue Reading
AI Adoption Institute Targets ROI with Peer Circles

Updated Category News Views 102

Transforming AI from Cost to Profit Alright folks, we all know AI's the flashy tool everyone's jumping on like it's the latest tech bandwagon. But here’s the raw deal: most of these shiny AI investments ain't paying back a damn thing. Enter the AI Adoption Institute (AiAi)—a new player in Denver aiming to salvage this mess and make AI about actual returns. Peering...

Continue Reading
AppLovin Faces Class Action as Promises Fall Short

Updated Category News Views 65

Class Action Shadows AppLovin Over AI Promises What a tangled web AppLovin has woven for itself. Promises of rapid AI advancements and a slick video tool rollout seemed like a done deal back in the early months of 2026. Well, that was until the cracks started to show by August. Promises Made, Promises Broken The saga kicked off on May 6, 2026, with AppLovin's confident...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Weigh In: The Current Landscape for Riot Platforms

Updated Category News Views 156

Investors Assess the Options Market for Riot Platforms In today’s trading environment, investors have embraced a pessimistic outlook on Riot Platforms (NASDAQ: RIOT). This comes as no surprise given the substantial movements detected in the options market, indicating that something notable might be on the horizon for Riot. The notable activity is significant, showcasing...

Continue Reading
Herantis Pharma's HER-096 Achieves Milestone in Parkinson's Study

Updated Category News Views 255

Herantis Pharma Celebrates Positive Outcomes in Parkinson’s Trial Herantis Pharma has made substantial strides in its quest to develop effective therapies for those living with Parkinson’s disease. The company recently shared exciting topline results from its Phase 1b trial conducted with HER-096, a promising candidate designed to tackle the challenges of this...

Continue Reading
Beezie Unleashes New Innovations in Collectibles Resale Market

Updated Category News Views 293

Beezie Redefines the Collectibles Resale Game In an exciting development within the collectibles market, Beezie is pioneering new approaches to how resellers manage and sell high-value items like trading cards, sneakers, and memorabilia. With its innovative platform, Beezie has introduced gamification and secure vaulting, setting a new standard in the industry....

Continue Reading
Investigation into agilon health, inc.: Your Rights As an Investor

Updated Category News Views 172

Investigating Potential Claims for agilon health, inc. Investors In recent developments, shareholders of agilon health, inc. (NYSE: AGL) find themselves under scrutiny due to potentially misleading information that may have impacted their investments. The Rosen Law Firm, a respected global investor rights legal firm, is actively investigating these possible securities...

Continue Reading
Crédit Agricole S.A. Announces New Share Buyback Initiative

Updated Category News Views 265

Crédit Agricole S.A. Announces New Share Buyback Initiative Crédit Agricole S.A. is set to launch an exciting new chapter in its financial journey. The company has received all necessary supervisory approvals to commence a share repurchase program targeting up to 22,886,191 ordinary shares. This initiative is not only a strategic maneuver but also reflects the...

Continue Reading